Introduction Consegna specializes in reformulating existing FDA-approved drugs to create innovative long-acting injectable (LAI) medications that provide enhanced clinical and economic advantages. The company's product pipeline is centered on therapeutic areas where LAIs can deliver significant therapeutic and economic benefits, such as improving patient adherence, overcoming drug delivery challenges, and minimizing side effects. |